Downloads provided by UsageCounts
AimTo clarify the high variability in COVID-19-related deaths during the first wave of the pandemic, we conducted a modeling study using publicly available data.Materials and methodsWe used 13 population- and country-specific variables to predict the number of population-standardized COVID-19-related deaths in 43 European countries using generalized linear models: the test-standardized number of SARS-CoV-2-cases, population density, life expectancy, severity of governmental responses, influenza-vaccination coverage in the elderly, vitamin D status, smoking and diabetes prevalence, cardiovascular disease death rate, number of hospital beds, gross domestic product, human development index and percentage of people older than 65 years.ResultsWe found that test-standardized number of SARS-CoV-2-cases and flu vaccination coverage in the elderly were the most important predictors, together with vitamin D status, gross domestic product, population density and government response severity explaining roughly two-thirds of the variation in COVID-19 related deaths. The latter variable was positively, but only weakly associated with the outcome, i.e., deaths were higher in countries with more severe government response. Higher flu vaccination coverage and low vitamin D status were associated with more COVID-19 related deaths. Most other predictors appeared to be negligible.ConclusionAdequate vitamin D levels are important, while flu-vaccination in the elderly and stronger government response were putative aggravating factors of COVID-19 related deaths. These results may inform protection strategies against future infectious disease outbreaks.
Europe (Central), SARS-CoV-2, COVID-19, vitamin D, influenza vaccination, Europe, COVID-19; Europe; Flu vaccine; Generalized linear models; Lethality; Non-pharmaceutical interventions; SARS-CoV-2; vitamin D, SARS-CoV2, Influenza, Human, Humans, Public Health, Public aspects of medicine, RA1-1270, Vitamin D, non-pharmaceutical interventions, Pandemics, Aged
Europe (Central), SARS-CoV-2, COVID-19, vitamin D, influenza vaccination, Europe, COVID-19; Europe; Flu vaccine; Generalized linear models; Lethality; Non-pharmaceutical interventions; SARS-CoV-2; vitamin D, SARS-CoV2, Influenza, Human, Humans, Public Health, Public aspects of medicine, RA1-1270, Vitamin D, non-pharmaceutical interventions, Pandemics, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
| views | 12 | |
| downloads | 22 |

Views provided by UsageCounts
Downloads provided by UsageCounts